LEIGH FOX: Open Payments
NPI 1356725717 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,686 in 186 payments from 14 companies in 2025. Trend: 2023 $2,810 · 2024 $2,327 · 2025 $2,686
Food & beverage: $2,596Education: $90
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 49 | $568 |
| Janssen Biotech, Inc. | 32 | $567 |
| Madrigal Pharmaceuticals | 27 | $443 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $285 |
| Ardelyx, Inc. | 22 | $262 |
| ABBVIE INC. | 22 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| PFIZER INC. | 3 | $61 |
| Braintree Laboratories, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $30 |
Products named: VOQUEZNA, TREMFYA, REZDIFFRA, XIFAXAN, IBSRELA, SKYRIZI, RINVOQ, CREON.
Industry payments across KY — which companies pay providers there.
